# Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers

> **NCT02215941** · PHASE1 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** TV-45070
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02215941
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-11
- **Final completion:** 2015-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215941, "Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02215941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*